Allogene Therapeutics, Inc.

HSBC HOLDINGS PLC ALLO

Report date

12/31/2025

Quarter

2025 Q4

Filed

3/6/2026

Shares

148,136

Value ($000)

199

Weight

0.0%

2020 Q1 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	3/6/2026	199	0.0%	148,136	12/31/2025
2025 Q3	11/13/2025	114	0.0%	94,065	9/30/2025
2025 Q2	8/13/2025	115	0.0%	98,491	6/30/2025
2025 Q1	5/14/2025	115	0.0%	81,435	3/31/2025
2024 Q4	2/14/2025	147	0.0%	69,155	12/31/2024
2024 Q3	11/14/2024	148	0.0%	52,387	9/30/2024
2024 Q2	8/12/2024	103	0.0%	44,664	6/30/2024
2024 Q1	5/15/2024	242	0.0%	54,116	3/31/2024
2023 Q4	2/12/2024	142	0.0%	44,664	12/31/2023
2023 Q3	11/13/2023	51	0.0%	16,155	9/30/2023
2022 Q2	8/11/2022	131	0.0%	11,500	6/30/2022
2022 Q1	5/16/2022	261	0.0%	28,429	3/31/2022
2021 Q4	2/11/2022	251	0.0%	16,749	12/31/2021
2021 Q3	11/12/2021	698	0.0%	27,067	9/30/2021
2021 Q2	8/13/2021	1,111	0.0%	42,460	6/30/2021
2021 Q1	5/14/2021	406	0.0%	11,500	3/31/2021
2020 Q4	2/25/2021	395	0.0%	15,610	12/31/2020
2020 Q3	11/12/2020	634	0.0%	16,766	9/30/2020
2020 Q2	8/14/2020	492	0.0%	11,500	6/30/2020
2020 Q1	5/15/2020	245	0.0%	12,939	3/31/2020